Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 218

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 218
---
jections were generated or to reflect the occurrence of future events, except as otherwise required by law.

In light of the foregoing, as well as the uncertainties inherent in any forecasted information, Channel Stockholders and LNHC Stockholders are cautioned not to place undue reliance on such information, and each of Channel and LNHC caution you that the LNHC Projections should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding LNHC contained elsewhere in this information

<div align='center'>120</div>

TABLE OF CONTENTS

statement. You are urged to read the sections entitled “ Cautionary Note Regarding Forward-Looking Statements” and “ Risk Factors” of this information statement, for additional information regarding the risks inherent in forward-looking information such as the LNHC Projections.

| ($ in mm)      |     |   2025E |     |   2026E |     |  2027E |     |   2028E |     |   2029E |     |   2030E |     |   2031E |     |   2032E |     |   2033E |     |   2034E |
| Net Revenue    |     |   $8.46 |     |  $47.63 |     | $95.38 |     | $144.75 |     | $167.48 |     | $194.14 |     | $211.30 |     | $225.41 |     | $248.02 |     | $263.89 |
| Gross Profit   |     |   $7.20 |     |  $42.38 |     | $86.23 |     | $132.35 |     | $153.22 |     | $178.28 |     | $195.18 |     | $208.30 |     | $229.07 |     | $243.83 |
| EBITDA         |     | -$35.65 |     |  -$7.13 |     | $28.18 |     |  $65.43 |     |  $81.47 |     | $101.03 |     | $108.00 |     | $117.48 |     | $133.19 |     | $143.96 |
| Net Income     |     | -$36.46 |     |  -$9.00 |     | $25.42 |     |